U.S. University Consortia: ACHIEVE

Summary of Site

The Makerere University College of Health Sciences (MaKCHS) is one of the oldest and most prestigious universities in Africa.

Primary Contact

• Melissa Reyes, mr8182@nyu.edu, Training Programs Manager (contact for letter of affiliation) 

Areas of Focus

Fellows would be expected to work with U.S. and Ugandan mentors to develop an independent research project that could be integrated into one of the following projects or in a new area of interest:

• Family and child health, maternal and reproductive health
• Gender-based violence
• Communicable and non-communicable disease epidemiology
• Environmental health, community engagement
• HIV prevention, care, and treatment

Sample Research Projects

• Diagnosing Alzheimer's disease as a platform for improving training in geriatrics in Uganda, MaK RIF 2020-2023
• The Impact Of The Covid-19 Pandemic And Its Response On The Mental Health Of People With Pre-Existing Mental Conditions In Uganda
• Picture of ageing in Uganda 
• Effectiveness and Implementation of an Early Childhood School-Based Mental Health Intervention in Low-Resource Communities, NIMH, 2020-2024 Huang (NYU), Nakigudde, (MUK)
• Predicting and Preventing Tuberculosis Treatment Failure in an Emerging Co-Epidemic of HIV, Diabetes, and Tuberculosis. Patterson Trust, 2019-2021, Armstrong-Hough (NYU)
• Mental health and Cognition in HIV infection in Rakai Uganda. NIMH, 2019-2024 (Nakasujja, Co-I) Nakasujja (MUK)
• Malarial Impact on Neurobehavioral Development. NINDS, 2019-2024 Nakasujja, Bangirana (MUK)
• Psychosis genetics Research in Africa: Building capacity by investing in people (Akena) 
• Early interventions for  psychosis using measurement based care (Mwesiga)

Language Requirement

None

U.S. University Consortia: ACHIEVE 

Summary of Site

Mildmay Uganda is a national Non-Government Organization established in Uganda in 1998 as a Centre of Excellence for the provision of comprehensive HIV & AIDS prevention, care, treatment, and training services. Over time, Mildmay Uganda has evolved and diversified its services specializing in the delivery of comprehensive healthcare including Treatment Services; Health Systems Strengthening; Other Complementary Social Services; Health Training and Education; and Research.

Mildmay Research Centre Uganda (MRCU) is a subsidiary of Mildmay Uganda (MUg). MUg is a national indigenous, faith-based organization registered under Uganda’s law with the national NGO Registration Board as a non-government organization (NGO) with affiliates in the UK and Kenya. SINCE 1998, MUg has been modeling quality and sustainable prevention, care and treatment of HIV and other health priorities, using a family-centered approach together with training, education and research in Uganda. MUg pioneered specialist paediatric HIV care in sub-Saharan Africa and is one of the two paediatric palliative care Beacon Centres in Africa. For over 21 years now, MUg has been, and is a key player in the HIV epidemic response in Uganda providing prevention, care, treatment and Health Systems Strengthening services across several districts of Uganda and at its Center of Excellence (CoE). MUg has demonstrable capacity to pinpoint and focus her intervention to the most vulnerable people and deploys low-cost models that high impact yet replicable. MUg is one of the National NGOs (NNGOs) operating sub-national programs that contribute significantly to national health outcomes and is currently the PEPFAR comprehensive implementing partner for Central Uganda (the region with highest HIV prevalence of 7.2% compared to 5.8% national prevalence). Mildmay Uganda management systems, including her laboratory, are accredited for ISO 9001:2015 and 15189:2012 respectively.

Primary Contacts

• Anna Foster, a.e.foster@wustl.edu, Training Programs Manager 

Areas of Focus

Fellows would be expected to work with U.S. and Ugandan mentors to develop an independent research project that could be integrated into one of the following projects or in a new area of interest:

• Sexual and Reproductive Health (SRH)
• HIV Prevention, Care & treatment
• Key populations
• Infectious Diseases
• Non-Communicable Diseases
• Biomedical Research
• Dementia and Mental Health among others

Sample Research

• RIA2017MC-2009 (J. Mukonzo, PI) 06/01/2020 -06/30/2024 EDCTP: Safety and efficacy DTG and EFV400 for pregnant and breast-feeding women: a randomized non-inferiority clinical trial (PREGART).
• UVRI/IAVI funded by Glaxo SmithKline; Using implementation research to understand the impact and effectiveness of the Paediatric Breakthrough Partnership (PBP)
• GH002046-18033-Mubende (B. Mukasa, PI) 20/11/2017- 20/11/2023 CDC: Baseline, Midterm and End of Project Evaluation Protocol for Mildmay Mubende region: Midterm Review of Accelerating HIV Epidemic Control in 8 Districts of Mubende Region.
• R01MH110350 (S. Linnemayr, PI) 09/13/2017-10/14/2022 NIH/NIMH-Behavioral Economics Incentives to Support HIV Treatment Adherence in Sub- Saharan Africa.
• R01HD074949(Ssewamala/Sensoy/Nabunya,PI) 09/01/2020- 07/31/2025: NIH/NICHD: Suubi+Adherence-R2: Examining the longitudinal HIV treatment adherence among youth living with HIV (YLHIV) transitioning into young adulthood.
• R01MH115830 (G. Wagner, PI) 08/15/2018-05/08/2023-NIH/NIMH: Depression Care to Improve Adherence to PMTCT Care Continuum & Pregnancy Outcomes.
• R34MH119924-01A1 (L. Bogart, PI) 04/01/2020-03/31/2023 NIH - Implementation of Community-Based PrEP provision for Uganda Fisher Folk.
• R01HD104555 (Huang/Linnemayr, PI) 05/2021 – 01/ 2026NIH/NIMH: Goals for Adherence with Low-cost Incentives (GOALS).
• R34MH122331 (S. Linnemayr, PI) 09/01/2020 -08/31/2023 NIH/NIMH: Incentives and ReMINDers to Improve Long-term Medication Adherence (INMIND).
• HS1273ES (Ndagije/Mukasa, PI) 10/02/2020 – 09/30/2022 Uganda National Drug Authority (NDA): Evaluating the Glycemic Effects of Dolutegravir (DTG) among Patients Receiving Dolutegravir Based Regimens at Mildmay Uganda ART sites.
• 1K01MH121663-01A1 (K. Sileo, PI) 08/01/2020 – 12/31/2023 NIH: A Gender Transformative Strategy with providers to Improve HIV Outcomes in Uganda.
• Improving Antiretroviral Treatment (ART) adherence (Adolescents).
• The WiseMama study was designed to provide evidence on the feasibility and effectiveness of a wise pill device in helping HIV-positive pregnant and post-partum women (PPPW) to maintain high adherence to antiretroviral (ARV) medications.
• Behavioral studies on the Impact of COVID-19 on ART adherence.
• Sexual Reproductive Health: Studies for Delivery of Sexual and Reproductive Health services using community models among vulnerable population in Uganda including urban refugees.
• HIV prevention strategies: Mildmay research center has together with partners implemented research with funding from International Initiative for Impact Evaluation (3ie) to test and evaluate new interventions of testing for HIV at community level using the Self Testing approach (Oral quick).
• Non-Communicable Diseases: Past research on Computerized Cognitive Rehabilitation training for Ugandan older persons living with HIV revealed that this rehabilitation approach may be a useful non-pharmacologic intervention for mitigative neurocognitive decline and aging related disability for older African persons especially those living with HIV.

Language Requirement

None

U.S. University Consortia: ACHIEVE 

Summary of Site

The Uganda Cancer Institute (UCI) was established in 1967 as a result of a collaboration between Makerere University, the Ministry of Health and the US National Cancer Institute. It was established as a treatment center for the then recently discovered Burkitt Lymphoma, although it was subsequently expanded to treat other cancers with the Opening of the Solid Tumor Centre (STC) in 1969. The UCI is recognized as the site of the description of Burkitt Lymphoma by Dr. Denis Burkitt and also one of the initial sites for the first use of combination chemotherapy for cancer, which now forms the basis of all cancer chemotherapy.

The Institute is a comprehensive cancer center offering all types of cancer care including radiotherapy, surgery, chemotherapy and palliative and rehabilitative services. The Institute caters for patients of all ages. The Institute currently receives over 7400 incident cases of cancer every year of which about 700 are children (< 14 years of age). The commonest cancers are cervical cancer, breast cancer and prostate cancer. Based on the Kampala Cancer Registry (KCR), Uganda has one of the highest cervical cancer incidence rates in the world with an age standardized rate of 47.5 per 100,000 which is three times higher than the global average estimate of 15.8 per 100,000. Prostate cancer is the commonest cancer in men with an annual incidence rate of 20.2% (2,288 cases). Childhood (pediatric) cancers comprise about 10% of the total annual incidence of cancers at the Uganda Cancer Institute.

The Institute has also been designated as the East Africa Centre of Excellence in Oncology and is in the process of establish four regional cancer centers in different parts of Uganda.

Primary Contacts

• Melissa Reyes, mr8182@nyu.edu, Training Programs Manager

Areas of Focus

The Uganda Cancer Institute was started in the first place to provide room for research and clinical initiatives in cancer. The institute has over the past few years, built capacity to conduct high-quality research including clinical trials, implementation science and community studies. Our research provides avenues for discovery but also additional treatment options for patients such as in clinical trials.

Fellows coming to the Uganda Cancer Institute would be expected to work with U.S. and Ugandan mentors to develop an independent research project that could be integrated into one of the following projects or in a new area of interest:

• Improving pediatric oncology supportive care in a resource-limited setting
• Cancer biology
• Implementation science research
• Oncology/Hematology
• Sociobehavioral and socio-economic cancer research
• Genomics
• Cancer epidemiology and registration
• Early detection and diagnosis

Sample Research

• Addressing the burden of untreated HIV in adult cancer patients in sub-Saharan Africa: Feasibility and planning for a pragmatic clinical trial (Rachel Ignacio Bender (UW), Noleb Mugisha (UCI), Niyonzima (UCI)
• Exploring the impact of COVID-19 on cancer prevention and control service delivery in Uganda (Kirsten Beyer (UM), Nixon Niyonzima (UCI)
• Defining the molecular profile of breast cancer in Uganda and its clinical implications (Manon Menon (Fred Hutch), Jackson Orem (UCI))
• A Pilot Study of Nelfinavir for the Treatment of Kaposi Sarcoma: a Trial of the AIDS Malignancy Consortium (AMC) 098 (AMC, Jackson Orem (UCI))
• Assessing the Clinical Utility of an Automated Molecular Diagnostic Test (GeneXpert Breast Cancer STRATA4 Assay) in the Diagnosis of Women with Breast Cancer in Uganda (Manoj Menon (Fred Hutch), Niyonzima (UCI)

Language Requirement

None

Summary of Site

The Makerere University College of Health Sciences (MaKCHS) is one of the leading health sciences universities in Sub-Saharan Africa. Its mission is to improve the health of people of Uganda through innovative teaching and research and the provision of services responsive to societal needs. Research opportunities with two different research groups at MakCHS are listed below.

Primary Contacts

• Luke Davis, MD (contact for letter of affiliation), U.S. Mentor (U-TIRC), Associate Professor of Epidemiology (Microbial Diseases) and of Medicine (Pulmonary); Affiliated Faculty, Yale Institute for Global Health, Yale University, lucian.davis@yale.edu
• Jeremy Schwartz, MD, Associate Professor of Medicine (General Medicine) and Epidemiology (Chronic Disease), Yale University, jeremy.schwartz@yale.edu
• Sunil Parikh, MD, MPH, Professor of Epidemiology (Microbial Diseases) and Medicine (Infectious Diseases), Yale School of Public Health, sunil.parikh@yale.edu

Areas of Focus

• Tuberculosis
• HIV
• Non-communicable diseases
• Implementation science

Sample Research Projects

• Uganda Initiative for Noncommunicable Diseases (UINCD) Projects. UINCD is hosting the following implementation research projects related to noncommunicable diseases (NCDs), including in the context of HIV:
  • ImpleMEntation of a Digital-first care deLiverY model for heart failure in Uganda (MEDLY Uganda) (funded by NIH)
  • An mHealth implementation strategy to address the syndemic of mental illness, hypertension, and HIV in Uganda (funded by NIH)
  • Implementation of PEN-Plus, a WHO-adopted integrated care strategy to increase the quality of services for severe chronic conditions at referral centers (funded by Partners in Health)

• Uganda Tuberculosis Implementation Research Consortium (U-TIRC) Projects. U-TIRC is hosting the following implementation research projects related to tuberculosis (TB), including in the context of HIV:
  • Human-Centered Design and Communities of Practice for TB Contact Investigation in Uganda (funded by NIH)
  • Expanding provision of TB preventative therapy through home-based services in Uganda (funded by TB REACH)

• Makerere University/Infectious Diseases Research Collaboration/Gulu University. The Parikh Lab has a long-standing (20+ years) collaboration with established investigators in malaria and HIV-malaria co-infection based in southeast Uganda and Kampala. There is also an opportunity to work in Northern Uganda with a new collaboration with Dr. Richard Echodu at Gulu University. Research focus areas include trials on antimalarial efficacy, drug resistance, and parasite dynamics in children/pregnant women with and without HIV. One of the most recently launched studies focuses on emerging artemisinin resistance in Northern Uganda.

Language Requirement

None

U.S. University Consortia: GloCal

Summary of Site

The Infectious Diseases Institute is a Ugandan non-government organization owned by Makerere University (Uganda). Its mission is “To strengthen health systems in Africa through research and capacity building”. IDI provides comprehensive services for over 250,000 people with HIV and other infectious diseases in Uganda. 

The research program at IDI hosts more than 100 research projects, of which 20 are clinical trials, and two include specific capacity-building components. IDI maintains collaborations with several US and European institutions and is also a research partner in clinical trials networks in Africa.

The Research Office provides administrative and regulatory support and oversight, as well as internal monitoring. A regulatory officer guides investigators and scholars to ensure compliance with local and international regulations. The research program also hosts an independent Research Ethics Committee (IDI-REC).

The Research Capacity Building Unit within the research department provides a structure for capacity building activities nested in research projects and partnership. This structure consists of infrastructural support, management of finances and resources, local mentorship (and international links to more senior mentors when needed), training, and connection to the IDI scholar community for peer support and exchange. 

All scholars and research fellows at IDI, while working within their proposed project, are integrated in the capacity building Unit and are offered support through: orientation on the Capacity Building Program, assignment of a local mentor, quarterly progress evaluations, journal clubs, research fellows peer support clubs, a short course on scientific writing, soft skills training (e.g. how to formulate a research questions, how to present, PowerPoint skills etc.). In addition to supporting scholars with degree and publications goals, the Unit aims to equip scholars with the skills necessary to pursue a career as an independent researcher.

Primary Contacts

• Dr. Barbara Castelnuovo, GloCal IDI Site PI, bcastelnuovo@idi.co.ug (contact for letter of affiliation)
• Dr. Craig Cohen, GloCal UCSF PI, craig.cohen@ucsf.edu (additional contact)

Areas of Focus

• HIV
• Tuberculosis & related conditions
• Malaria

Language Requirement 

None

U.S. University Consortia: GloCal

Summary of Site

The Infectious Diseases Research Collaboration is a research partnership established in 1998 by Drs. Moses Kamya of Makerere University (MU) and Phil Rosenthal of the University of California, San Francisco (UCSF). The IDRC conducts a broad range of infectious disease research, including malaria, HIV, and tuberculosis (TB), using molecular, clinical, epidemiological, and implementation science approaches. 

The collaboration includes several dozen faculty members from both MU and UCSF, and is managed by IDRC, with an annual operating budget of approximately $9 million and about 50 publications each year. Some of the important projects that can be leveraged for training of GloCal and Fulbright-Fogarty fellows include: 

• A Multisectoral Strategy to Address Persistent Drivers of the HIV Epidemic in East Africa (SEARCH SAPPHIRE study).
• Program for Resistance, Immunology, Surveillance, and Modeling of Malaria in Uganda (PRISM study).
• A series of randomized trials evaluating optimal malaria prevention and control practices for pregnant women and their children in Tororo. 
• Programs studying immune responses to malaria infection, antimalarial drug resistance and treatment efficacy, antiretroviral therapy initiation, HIV-associated pneumonia, and TB.

IDRC collaborative programs have trained and built the capacity of over 80 Ugandan junior scientists and administrators.

Primary Contacts

• Dr. Moses Kamya, GloCal IDRC Site PI, mkamya@idrc-uganda.org (contact for letter of affiliation)
• Dr. Craig Cohen, GloCal UCSF PI, craig.cohen@ucsf.edu (additional contact)

Areas of Focus

• HIV
• Tuberculosis & related conditions
• Malaria

Language Requirement 

None

U.S. University Consortia: GloCal

Summary of Site

The World Alliance for Lung and Intensive Care Medicine in Uganda (WALIMU) is a Uganda-registered non-governmental organization established in 2013 to support health workers in delivering high-quality, evidence-based clinical care. WALIMU was founded in response to the recognition that many patients in low-resource settings die from treatable conditions because severe illness is not identified and managed early enough. Through implementation research and health systems innovation, WALIMU develops and evaluates strategies to strengthen clinical systems, with a focus on early recognition and management of severely ill patients.

WALIMU is a nationally recognized leader in clinical systems strengthening and implementation science and has partnered with the World Health Organization and the Uganda Ministry of Health to scale up severe illness management guidelines across district hospitals nationwide. WALIMU also plays a key role in training health workers in preparedness and response to viral hemorrhagic fevers, including Ebola and Marburg disease, and conducts research on the causes and management of sepsis and severe infections in Ugandan hospitals.

In 2019, WALIMU expanded its research portfolio to include tuberculosis by bringing the Uganda TB Implementation Research Consortium (U-TIRC) into its administrative structure. Established in 2008, U-TIRC brings together investigators from Makerere University, the Uganda Ministry of Health and National TB and Leprosy Program, and international partners including UCSF, Yale University, Johns Hopkins University, and the London School of Hygiene and Tropical Medicine. U-TIRC conducts clinical, epidemiological, and implementation science research to improve TB prevention, diagnosis, and treatment and inform national TB policy.

U-TIRC also supports research capacity building through the NIH-funded D43 Pulmonary Complications of AIDS Research Training (PART) program, which provides Ugandan Master’s and PhD trainees with mentored research support and training in mixed methods and implementation science. Administrative and operational support is provided through WALIMU’s Kampala offices. Together, WALIMU and its partners and collaborators provide a strong mentorship environment for GloCal and Fulbright-Fogarty fellows interested in implementation science/research, capacity building, policy, and more.

Primary Contacts

• Dr. Achilles Katamba, GloCal U-TIRC Site PI, amkatamba@gmail.com (contact for letter of affiliation)
• Dr. Craig Cohen, GloCal UCSF PI, craig.cohen@ucsf.edu (additional contact)

Areas of Focus

• Tuberculosis prevention, diagnosis, and treatment

Language Requirement

None

U.S. University Consortia: HBNU

Summary of Site

Mbarara University of Science and Technology (MUST) is located in Mbarara Municipality, southwest of Kampala, the capital city of Uganda. MUST is a public university accredited by the National Council for Higher Education in Uganda. It has acclaimed national and international recognition for best practices in outreach and community relations from Association of Commonwealth Universities, European Union, Civil Society of Uganda, and produces exceptional development workers and health care professionals. Its vision as a leading institution is to be a center of academic and professional excellence in Science and Technology with the goal of providing quality and relevant education at national and international level with particular emphasis on Science and Technology and its application to community development. 

MUST shares a campus with Mbarara Regional Referral Hospital (MRRH). It is the sole teaching and referral hospital for southwest Uganda and the Ministry of Health provides MRRH with regular medical supplies, free antiretrovirals and medications, and diagnostic equipment. The Immune Suppression Syndrome (ISS) Clinic, a PEPFAR-funded clinical site, serves as the hospital’s HIV outpatient clinic, and is run primarily by the Department of Internal Medicine at MUST. The HIV clinic at MUST and MRRH cares for 12,000 active patients living with HIV, with approximately 1,000 patients initiating ART each year.

Harvard University and Boston University have worked in partnership with MUST for many years to conduct important research and train early-career researchers. Research collaborations have addressed a variety of basic science, clinical research, and implementation science topics, including projects to examine HIV co-morbidities, malaria case management, and maternal mental health, amongst others. HBNU is seeking to continue this history of collaboration through the hosting of Fulbright-Fogarty Fellows. Fellows would be expected to work with their US and Ugandan mentors to develop a research project related to ongoing work or in a new area of interest.

Primary Contacts

• Professor Wafaie Fawzi, Professor of Global Health, Nutrition, and Epidemiology; Department of Global Health and Population, Harvard Chan School of Public Health, mina@hsph.harvard.edu 
• Kemjika Nwokogba, Senior Program Manager, Harvard Chan School of Public Health, nwokogba@hsph.harvard.edu 

Interested Fulbright-Fogarty candidates should contact the two listed project contacts directly to express their interest. In your message, indicate whether you have already identified a project mentor or if you would like assistance in identifying and/or contacting potential mentors.

Please include: 

• A brief statement of interest (one paragraph), and 
• Your CV/resume as an attachment. 

For your application, you will need to identify a suitable site mentor from the HBNU training site and contact them directly to inquire about mentorship for your proposed project and to request a letter of support. We are available to assist with this process; however, applicants may also reach out directly to mentors listed on our website under HBNU Training Sites and Mentors: https://hsph.harvard.edu/fellowship-special-program/hbnu-fogarty/hbnu-training-sites-and-mentors/#LMIC-Mentors

Areas of Focus 

• Maternal and Child Health and Nutrition 
• Adolescent Health 
• Infectious Disease 
• Mental Health 
• Non-communicable Diseases

Language Requirement 

None

U.S. University Consortia: INSIGHT 

Summary of Site

Mbarara University of Science & Technology (commonly known as MUST), a public university in Uganda commenced student intake and instruction in 1989 and is one of the ten public universities and degree-awarding institutions in the country. MUST is accredited by the National Council for Higher Education in Uganda and has acclaimed national and international recognition for best practices in outreach and community relations from Association of Commonwealth Universities, European Union and the Civil Society of Uganda. The Mbarara Regional Referral Hospital (MRRH) is the sole teaching hospital for the MUST Medical School and is the referral hospital for the Western Region of Uganda. The 320 bed referral hospital provides outpatient and inpatient clinical care, training, and research infrastructure in southwestern Uganda - a region 36,870 square kilometers in size with a population of over 5 million representing about 18% of the national population. MRRH houses the Immune Suppression Syndrome Clinic (ISS Clinic), a PEPFAR-funded clinical site, which serves as the hospital’s HIV outpatient clinic.

Primary Contacts

INSIGHT Program Managers, University of Alabama at Birmingham 

• Anna Helova, ahelova@uab.edu 
• Tayyaba Khan, khan14@uab.edu 

Areas of Focus

• HIV care
• HIV prevention
• Reproductive health
• Health sciences education
• Human medicine
• Nursing
• Medical laboratory sciences
• Pharmacy
• Pharmaceutical sciences
• Physiotherapy
• Interdisciplinary healthcare delivery through community-based education, research, and service (COBERS)

Language Requirement

None

U.S. University Consortia: NPGH

Summary of Site

The University of Minnesota has a long-standing research relationship with multiple colleges at Makerere University (Infectious Disease Institute, College of Health Sciences, School of Medicine, and the College of Veterinary Medicine, Animal Resources, and Biosecurity) starting in 2005 and with Mbarara University starting in 2010 regarding neuro-infectious disease research. The University of Minnesota has enabled training for 7 PhDs and 13 master’s Ugandan trainees through nested projects of NIH-sponsored clinical research. Since 2012, 20 Fogarty Scholars and Fellows have been trained in this capacity through 1-year global health fellowships (1 at MUST, 19 at Makerere). Additionally, three Ugandan principal investigators have obtained independent NIH funding. 

The University of Minnesota has strong resources to support research fellows through an extensive network of researchers at all three institutions committed to advancing research training.

Primary Contact

• Dr. Shailey Prasad, Shailey@umn.edu, University of Minnesota 

Areas of Focus

• HIV and Cryptococcal Meningitis 
• Epidemiology and surveillance systems for infectious disease and zoonotic infection
• Mobile health interventions (women’s health and HIV)
• Immunology
• Neuropsychology
• Nutrition (primarily pediatric) and infectious disease 
• Vaccine research

Language Requirement

None

U.S. University Consortia: NPGH

Summary of Site

Mulago Hospital is the largest government referral hospital in Uganda and serves as the primary teaching hospital for Makerere University. Since the establishment of the UMN Uganda Hub in 2015, Mulago has been a central site for interdisciplinary research, education, and clinical training. It is a core location for the University of Minnesota’s Global Medical Education and Research (GMER) program, hosting clinical rotations for medical students and residents across nearly all medical specialties. The site supports a high volume of tertiary care and provides a rich environment for studying advanced pathology in resource-constrained settings.

Primary Contact

• Dr. Shailey Prasad, shailey@umn.edu, University of Minnesota 

Areas of Focus

• Internal Medicine (Infectious Disease, Neurology, Cardiology, and Nephrology)
• Pediatrics and Global Child Health
• Surgery and Obstetrics/Gynecology
• Emergency Medicine (Casualty) and Critical Care

Language Requirement

None 

U.S. University Consortia: UJMT

Summary of Site

Infectious Diseases Institute (IDI) is a Ugandan not-for-profit organization owned by Makerere University. Its mission is “to strengthen health systems in Africa, with a strong emphasis on infectious diseases, through Research and Capacity building.” IDI supports the Ministry of Health through providing both direct prevention, care and treatment services as well as technical assistance and health systems strengthening support in over 70 districts of Uganda. IDI has established long term international research collaborations with major academic centres worldwide (e.g., JHU, Harvard Medical School, UCSF, and many others) which provide a widening global dimension to research at IDI. IDI also participates in international networks such as such as the International Epidemiologic Databases to Evaluate AIDS: East Africa network (IeDEA); the East African Consortium for Clinical Research (EACCR), a European and Developing Countries Clinical Trials Partnership (EDCTP)-supported initiative; and Training Health Researchers into Vocational Excellence in East Africa (THRiVE), a Welcome Trust funded initiative (under the Makerere University umbrella).

Primary Contact

• Barbara Castelnuovo, bcastelnuovo@idi.co.ug 

Areas of Focus

Fellows would be expected to work with U.S. and Uganda based mentor groups to develop an independent research project that could be integrated into one of the following projects or in a new area of interest:

• ID epidemiology particularly STIs, tuberculosis, acute febrile illness
• Emerging infections and surveillance
• HIV, opportunistic infections, aging, and malignancies
• Programmatic implementation science – research to practice and policy

Language Requirement

None

U.S. University Consortia: UJMT

Summary of Site

The Makerere University College of Health Sciences (MakCHS) is one of the oldest and most prestigious universities in Africa, with over 40,000 students. It is the leading institution for medical instruction and research in the East, Central and Southern Africa (excluding South Africa). MakCHS has a strong track record of successful collaborative research with local, American and European universities and institutions and has participated in many of the early trials of HIV, tuberculosis, and malaria interventions in the region.

Primary Contact

• Bruce Kirenga, brucekirenga@yahoo.co.uk (contact for letter of affiliation)

Areas of Focus

Fellows would be expected to work with U.S. and Uganda based mentor groups to develop an independent research project that could be integrated into one of the following projects or in a new area of interest:

• Cancer
• Child health
• Communicable diseases (both non-HIV and HIV/AIDS)
• Noncommunicable diseases 
• Neurologic disorders
• Trauma and injury
• Women’s health
• Pulmonary health

Language Requirement

None

U.S. University Consortia: UJMT

Summary of Site

MU-JHU CARE Ltd (also known as ‘Makerere U.-Johns Hopkins U. Research Collaboration’) was first established in 1988 as a collaboration between investigators in the Departments of Obstetrics/ Gynaecology and Paediatrics at Makerere Univeristy School of Medicine and U.S. HIV Investigators. The MU-JHU Research Collaboration became incorporated as a not- for- profit local Uganda entity in 2006. For over 30 years, MU-JHU has been a leading research institution in Uganda with a sustained focus on HIV and women/maternal and pediatric health.

Primary Contact

• Philippa Musoke, pmusoke@mujhu.org (contact for letter of affiliation) 

Areas of Focus

Fellows would be expected to work with U.S. and Uganda based mentor groups to develop an independent research project that could be integrated into one of the following projects or in a new area of interest:

• HIV/AIDS
• Prevention of maternal to child transmission of HIV

Language Requirement

None

Rebel and bandit activity in the areas along the Sudanese border in northern Uganda and in the Democratic Republic of Congo (DRC) along the western border have in a few instances made these areas unstable and insecure. Caution should be exercised when carrying out research near these borders. For the latest security information, please review here. Fulbrighters are advised to check the site above for regular security updates, where the current travel warnings, travel alerts, and worldwide caution can be found.

The Uganda National Council of Science and Technology (UNCST) should approve all research projects, but candidates should not pay any fees until they are formally offered a Fulbright award. Candidates with projects involving human subjects may need to secure multiple ethical clearances. 

Medical facilities in Uganda, including in Kampala, are limited and not equipped to handle most emergencies, especially those requiring surgery. Outside of Kampala, hospitals are scarce and offer only basic services. Equipment and medicines are often in short supply or unavailable. Researchers should carry their own supplies of prescription drugs and preventive medicines.

Malaria is prevalent in Uganda. For additional information on malaria, including protective measures, see the Centers for Disease Control (CDC) Travelers Health website. Guidance on vaccinations and other health precautions may also be obtained from the CDC’s website. For information on outbreaks of infectious diseases abroad consult the World Health Organization (WHO) website. Further health details are available here.